Literature DB >> 22441874

Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.

Michelle E Ehrlich1.   

Abstract

Huntington's disease is an autosomal dominant disorder caused by a mutation in the gene encoding the protein huntingtin on chromosome 4. The mutation is an expanded CAG repeat in the first exon, encoding a polyglutamine tract. If the polyglutamine tract is > 40, penetrance is 100% and death is inevitable. Despite the widespread expression of huntingtin, HD has long been considered primarily as a disease of the striatum. It is characterized by selective vulnerability with dysfunction followed by death of the medium size spiny neuron. Considerable effort is being expended to determine whether striatal damage is cell-autonomous, non-cell-autonomous, requiring cell-cell and region to region communication, or both. We review data supporting both mechanisms. We also attempt to organize the data into common mechanisms that may arise outside the medium, spiny neuron, but ultimately have their greatest impact in the striatum.

Entities:  

Mesh:

Year:  2012        PMID: 22441874      PMCID: PMC3337013          DOI: 10.1007/s13311-012-0112-2

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  186 in total

Review 1.  The Nrf2-ARE cytoprotective pathway in astrocytes.

Authors:  Marcelo R Vargas; Jeffrey A Johnson
Journal:  Expert Rev Mol Med       Date:  2009-06-03       Impact factor: 5.600

2.  DARPP-32 genomic fragments drive Cre expression in postnatal striatum.

Authors:  Alexey I Bogush; Lois E McCarthy; Chai Tian; Vicki Olm; Tracy Gieringer; Sanja Ivkovic; Michelle E Ehrlich
Journal:  Genesis       Date:  2005-05       Impact factor: 2.487

Review 3.  Excitotoxic injury of the neostriatum: a model for Huntington's disease.

Authors:  M DiFiglia
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

4.  Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.

Authors:  Haibing Jiang; Michelle A Poirier; Yideng Liang; Zhong Pei; Charlotte E Weiskittel; Wanli W Smith; Donald B DeFranco; Christopher A Ross
Journal:  Neurobiol Dis       Date:  2006-09       Impact factor: 5.996

5.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

6.  Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity.

Authors:  O Hansson; A Petersén; M Leist; P Nicotera; R F Castilho; P Brundin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation.

Authors:  L Mangiarini; K Sathasivam; A Mahal; R Mott; M Seller; G P Bates
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

8.  Aging reduces neostriatal responsiveness to N-methyl-D-aspartate and dopamine: an in vitro electrophysiological study.

Authors:  C Cepeda; Z Li; M S Levine
Journal:  Neuroscience       Date:  1996-08       Impact factor: 3.590

9.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

10.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

View more
  50 in total

1.  Animal models of neurological disorders.

Authors:  Marie-Francoise Chesselet; S Thomas Carmichael
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 2.  The Tiny Drosophila Melanogaster for the Biggest Answers in Huntington's Disease.

Authors:  Abraham Rosas-Arellano; Argel Estrada-Mondragón; Ricardo Piña; Carola A Mantellero; Maite A Castro
Journal:  Int J Mol Sci       Date:  2018-08-14       Impact factor: 5.923

3.  FACS-array-based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model.

Authors:  Haruko Miyazaki; Tomoyuki Yamanaka; Fumitaka Oyama; Yoshihiro Kino; Masaru Kurosawa; Mizuki Yamada-Kurosawa; Risa Yamano; Tomomi Shimogori; Nobutaka Hattori; Nobuyuki Nukina
Journal:  J Biol Chem       Date:  2020-06-04       Impact factor: 5.157

4.  αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease.

Authors:  Ana Osório Oliveira; Alexander Osmand; Tiago Fleming Outeiro; Paul Joseph Muchowski; Steven Finkbeiner
Journal:  Hum Mol Genet       Date:  2016-02-26       Impact factor: 6.150

5.  Cell-Specific Deletion of PGC-1α from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment.

Authors:  Laura J McMeekin; Ye Li; Stephanie N Fox; Glenn C Rowe; David K Crossman; Jeremy J Day; Yuqing Li; Peter J Detloff; Rita M Cowell
Journal:  J Neurosci       Date:  2018-02-28       Impact factor: 6.167

6.  Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.

Authors:  Christina J Schier; William D Marks; Jason J Paris; Aaron J Barbour; Virginia D McLane; William F Maragos; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurosci       Date:  2017-05-04       Impact factor: 6.167

7.  Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice.

Authors:  Marta Garcia-Miralles; Michal Geva; Jing Ying Tan; Nur Amirah Binte Mohammad Yusof; Yoonjeong Cha; Rebecca Kusko; Liang Juin Tan; Xiaohong Xu; Iris Grossman; Aric Orbach; Michael R Hayden; Mahmoud A Pouladi
Journal:  JCI Insight       Date:  2017-12-07

8.  Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction.

Authors:  Justin Y Chen; Miloni Parekh; Hadear Seliman; Dariya Bakshinskaya; Wei Dai; Kelvin Kwan; Kuang Yu Chen; Alice Y C Liu
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

9.  Differential CaMKII regulation by voltage-gated calcium channels in the striatum.

Authors:  Johanna G Pasek; Xiaohan Wang; Roger J Colbran
Journal:  Mol Cell Neurosci       Date:  2015-08-05       Impact factor: 4.314

10.  Wheel running alters patterns of uncontrollable stress-induced cfos mRNA expression in rat dorsal striatum direct and indirect pathways: A possible role for plasticity in adenosine receptors.

Authors:  Peter J Clark; Parsa R Ghasem; Agnieszka Mika; Heidi E Day; Jonathan J Herrera; Benjamin N Greenwood; Monika Fleshner
Journal:  Behav Brain Res       Date:  2014-07-11       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.